Centre to cap trade margins on non-scheduled cancer drugs to 30% of MRP
1 hour ago · The Hindu
Global India
& newspaper;
Read Full Article →
Sourced From
The Hindu
Average trade mark-up on these drugs now around 170%, reaching 700% in some cases; intervention to cut prices by up to 70% of MRP, resulting in cumulative annual savings of ₹2,500 crore for patients
Source: The Hindu — Read full article →
Content sourced from third parties. Copyright belongs to original publishers.
Source: The Hindu — Read full article at source →
Content sourced from third parties. Copyright belongs to original publishers. Only excerpt and link are stored under fair use.